Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-alpha-2a with and without cytarabine in patients with chronic myelogenous leukemia (Q46689427)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-alpha-2a with and without cytarabine in patients with chronic myelogenous leukemia |
scientific article |
Statements
1 reference
Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-alpha-2a with and without cytarabine in patients with chronic myelogenous leukemia (English)
1 reference
Hagop Kantarjian
1 reference
Susan O'Brien
1 reference
Jorge Cortes
1 reference
Moshe Talpaz
1 reference
Ashok Rakhit
1 reference
Karen Rittweger
1 reference
Scott Fettner
1 reference
Leon Hooftman
1 reference
1 September 2005
1 reference
11
1 reference
17
1 reference
6247-6255
1 reference